Advisornet Financial’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Advisornet Financial's INSY Position: Q3 2019 in Review
Advisornet Financial sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 215 shares.
Advisornet Financial first reported a position in INSY in Q1 2018 and held it in 6 quarters. The position peaked at $1K in Q1 2019. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.
- Advisornet Financial reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Advisornet Financial sold 215 Insys Therapeutics, Inc. shares in Q3 2019.
- Advisornet Financial first reported a position in Insys Therapeutics, Inc. in Q1 2018 and held it in 6 quarters.
- Advisornet Financial's Insys Therapeutics, Inc. position peaked at $1K in Q1 2019.
- 4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.
Based on Advisornet Financial's 13F filing for Q3 2019, filed 23 Oct 2019.